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Summary
Familial combined hyperlipidemia (FCH) is a common
lipid disorder characterized by elevations of plasma cho-
lesterol and/or triglyceride in first-degree relatives. A
predominance of small, dense LDL particles and elevated
apolipoprotein B (apoB) levels is commonly found in
members of FCH families. Many studies have investi-
gated the genetic mechanisms determining individuals’
lipid levels, in FCH families. Previously, we demon-
strated a major gene effect on LDL particle size and
codominant Mendelian inheritance involved in deter-
mination of apoB levels in a sample of 40 well-defined
FCH families. An elevation of apoB levels is associated
metabolically with a predominance of small, dense LDL
particles in FCH. To establish whether a common gene
regulates both traits, we conducted a bivariate genetic
analysis to test the hypothesis of a common genetic
mechanism. In this study, we found that 66% of the
total phenotypic correlation is due to shared genetic
components. Further bivariate segregation analysis sug-
gested that both traits share a common major gene plus
individual polygenic components. This common major
gene explains 37% of the variance of adjusted LDL par-
ticle size and 23% of the variance of adjusted apoB
levels. Our study suggests that a major gene that has
pleiotropic effects on LDL particle size and apoB levels
may be the gene underlying FCH in the families we
studied.
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Introduction
Familial combined hyperlipidemia (FCH; MIM 144250)
is the most common form of lipid disorder, with an es-
timated population frequency of 1%–2%. Lipid profiles
in FCH families are characterized by elevated concen-
trations of total plasma cholesterol and/or triglyceride
in first-degree relatives; this disorder is therefore also
known as “multiple-type hyperlipidemia.” Other char-
acteristics of FCH include elevated plasma apolipopro-
tein B (apoB) levels, decreased HDL cholesterol concen-
tration, and a predominance of small, dense LDL
particles (Grundy et al. 1987; Kwiterovich et al. 1987;
Austin et al. 1990).
Originally, FCH was thought to be a single-gene dis-
order with a major effect on triglyceride levels and a
secondary effect on cholesterol levels (Goldstein et al.
1973). Several phenotypes, which include hyperapobe-
talipoproteinemia (Sniderman et al. 1980, 1982), LDL
subclass pattern B (Austin and Krauss 1986; Austin et
al. 1988), familial dyslipidemic hypertension (FDH)
(Hunt et al. 1989; Williams et al. 1993), and syndrome
X (Reaven 1988), have been proposed to have a rela-
tionship with FCH. These dyslipidemic syndromes ap-
pear related to each other through the presence of small,
dense LDL particles. The diverse metabolic and bio-
chemical defects suggest that the genetic basis of FCH
is heterogeneous (Kwiterovich 1993).
The cause of the mixed hyperlipidemia in FCH is un-
known and may vary among families. From a metabolic
point of view, there are two possible underlying defects:
(1) overproduction of apoB, and (2) delayed clearance
of triglyceride-rich lipoproteins (Kwiterovich 1993).
FCH is thought to be caused by hepatic overproduction
of apoB, which is channeled into a pool of very
low–density lipoprotein (VLDL) particles, resulting in
elevated levels of other apoB-containing lipoproteins,
which include intermediate density lipoprotein (IDL)
and LDL (Kissebah et al. 1981; Grundy et al. 1987;
Venkatesan et al. 1993). This “metabolic channeling”
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may explain the apparent increase in production of apoB
associated with a predominance of small, dense LDL
(Krauss 1994; de Graaf et al. 1993). Delayed clearance
of triglyceride-rich lipoproteins in FCH can be in part
caused by impaired lipoprotein lipase activity (Babirak
et al. 1989, 1992). Although high apoB levels and small,
dense LDL particles are strongly associated with an in-
crease in plasma triglyceride concentrations in FCH fam-
ilies, several studies have suggested distinct genetic mech-
anisms (Beaty et al. 1992; Hokanson et al. 1995) for
expression of elevated apoB levels and hypertri-
glyceridemia.
Previously, we have investigated the genetic mecha-
nisms of the distribution of dense LDL subfraction pro-
files (i.e., distribution of LDL density) and plasma apoB
levels in 40 well-defined Dutch FCH families, and a ma-
jor gene effect was found for each trait (Bredie et al.
1996, 1997). Since the distribution of LDL subfractions
is metabolically related to apoB levels, we here extend
our previous findings to investigate a common genetic
mechanism controlling both traits in these families.
Material and Methods
Study Population
The study population has been described elsewhere
(Bredie et al. 1996, 1997). In brief, families were ascer-
tained through probands exhibiting both cholesterol and
triglyceride concentrations 190th percentile, adjusted for
age and gender. Families were included when a multiple-
type hyperlipidemia with levels of total cholesterol and/
or triglyceride 190th percentile was present. If the body
mass index (BMI) exceeded 30 kg m2 or alcohol con-
sumption was more than two drinks (beer, wine) per day
(equivalent to 20 g of alcohol), the 95th percentile of
cholesterol and triglyceride was used. Thus, at least one
first-degree relative exhibited hypercholesterolemia or
hypertriglyceridemia, in addition to the proband. Fam-
ilies were excluded when probands had any underlying
diseases causing hyperlipidemia, probands were homo-
zygous for the apoE2 allele, or any first-degree family
member had tendon xanthomata. All individuals were
Caucasians above the age of 10 years. The study pro-
tocol was approved by the ethics committee of the Uni-
versity Hospital of Nijmegen.
Measurement of Lipid and LDL Subfraction
A detailed description of lipid assays has been given
previously (Bredie et al. 1996; 1997). In short, total
plasma apoB concentrations were determined by im-
munonephelometry (Lopes-Virella et al. 1980).
LDL subfractions were detected by single spin density
gradient ultracentrifugation, according to a method de-
scribed earlier (Swinkels et al. 1989). After ultracentri-
fugation the LDL subfractions were visible as distinct
bands in the middle of the tube. Up to five LDL sub-
fractions could be distinguished, concentrated in the fol-
lowing density ranges: LDL1 (1.030–1.033 g ml1),
LDL2 (1.033–1.040 g ml1), LDL3 (1.040–1.045 g
ml1), LDL4 (1.045–1.049 g ml1), and LDL5
(1.049–1.054 g ml1). The ultracentrifugation tubes con-
taining the LDL subfractions stained with Coomassie
Brilliant Blue R were placed in a specially designed rack
and photographed. Accurate documentation of the dif-
ferent LDL subfraction patterns was obtained by scan-
ning the obtained slides in triplicate on an LKB 2202
ultrascan laser densitometer (Pharmacia LKB, Uppsala,
Sweden). The mean peak heights (h1–h5) of the LDL
subfractions (LDL1–LDL5) on the three scans were used
to calculate the variable K as a continuous variable that
best describes each individual LDL subfraction pattern
(de Graaf et al. 1992). The relative contribution of each
LDL subfraction, expressed as the percent contributed
at each peak height (%h1–%h5) relative to the total
LDL subfraction profile [total LDL (100%) %h1
] was calculated. The rela-%h2%h3%h4%h5
tive peak heights of LDL3 and the less-frequently oc-
curring LDL4 and/or LDL5 were added to give
, where′%h3  (%h3%h4%h5) LDL(100%) 
. When a′LDL1(%h1) LDL2(%h2) LDL3(%h3 )
subfraction profile was characterized by a predominance
of buoyant LDL particles ( ), variable K wash1–h3 1 0
calculated by . In the′ ′K  (%h1–%h3 )/(%h2–%h3  1)
case of a predominance of heavy, dense LDL subfrac-
tions ( ), variable K was calculated by:h1–h3 ! 0 K 
. A negativeK value reflects′(%h1–%h3 )/(%h2–%h1 1)
a dense subfraction profile, reflects an interme-K  0
diate subfraction profile, and a positive K value reflects
a complete buoyant profile.
Statistical Analysis
To minimize other covariate effects on total plasma
apoB levels and variable K, crude phenotypic values (in-
cluding probands and all other family members) were
adjusted for gender, age, BMI, and smoking by linear
regression. The total sample mean was then added to
the residual value from each individual as the adjusted
value. The Spearman correlation coefficients between
apoB and variable K were calculated before and after
adjustment for covariates, to depict their relation.
Segregation Analysis
Bivariate segregation analysis of adjusted apoB and K
values was carried out by the computer program PAP
(version 4; Hasstedt 1994). For a trait under the control
of a single major gene, we assume that phenotypic var-
iation can be accounted for by a major gene effect, re-
sidual additive polygenes, and random environmental
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Figure 1 Histograms and Q-Q plots of adjusted variable K and apoB levels
factors for which we failed to adjust in the linear re-
gression models. Among the tested models, unobservable
genotypes are the products of two alleles, “A” and “B,”
at a single major gene. The B allele is associated with
higher levels of the trait, and A is associated with lower
levels. Thus, the general model includes three normal
distributions, denoted AA, AB, and BB, which are as-
sumed to occur in Hardy-Weinberg proportions in the
general population (i.e., , , and for each ge-2 2P 2P P PA A B B
notype, where PA is the frequency of A and P  1B
). Three means (mAA, mAB, and mBB) corresponding toPA
each genotype are estimated, along with a single com-
mon variance (F2). The within-genotype variance can be
further partitioned into a component representing resid-
ual polygenic effects (PG, also known as h2) and indi-
vidual specific environmental effects plus measurement
error (E, also known as ). Three arbitrary trans-21 h
mission parameters (tAA, tAB, and tBB) represent the prob-
ability that an individual of a given genotype transmits
an A allele to an offspring, and these are also estimated
under the most general single gene model.
Blangero and Konigsberg (1991) extended univariate
segregation analysis to multivariate segregation analysis
and implemented the maximum likelihood methods in
a modified version of PAP. When a second trait is in-
corporated into the model, the assumptions concerning
number of alleles per locus, Hardy-Weinberg equilib-
rium, relationship of alleles to higher and lower levels
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of the trait, and a single within-genotype variance are
the same as assumed above for the first trait. We used
bivariate models to estimate parameters corresponding
to apoB and variable K, simultaneously, as well as their
residual correlations from additive polygenes (rG) and
environmental (rE) factors. We postulated that the dis-
tribution of LDL subfraction profiles represented by var-
iable K is determined by an unobserved major gene
(a1G), residual additive polygenic background (a2PG),
and a residual nongenetic component (a3E); therefore,
variable K values are the sum of ,a G a PG a E1 2 3
with corresponding variance components 2j total
. Similarly, for the second trait, apoB2 2 2j  j  ja1G a2PG a3E
levels are the sum of , where the sameb G b PG b E1 2 3
underlying genetic factors (G and PG) exert different
effects (i.e., a and b) on variable K and apoB levels,
respectively. Path analysis can be used to describe the
correlation between two traits in the same individual.
As reviewed by Lynch and Walsh (1998), the genetic and
environmental correlations can be derived from the path
analysis, which calculates phenotypic correlation (rP) by
summing the appropriate products of path and corre-
lation coefficients:
2 2 2 2 ( ) ( )r  r h h  r 1 h 1 h .p G 1 2 E 1 2
When bivariate models do not incorporate a major gene
effect, h2 represents the proportion of the phenotypic
variance accounted for by the total additive genetic ef-
fects, and rG reflects the total genetic correlation between
two traits. When a major gene effect is incorporated into
models, h2 represents the proportion of the phenotypic
variance accounted for by the residual additive poly-
genes and rG represents genetic correlation from the
shared residual additive polygenes.
Since families were ascertained via two known af-
fected individuals, ascertainment correction was under-
taken by conditioning phenotypes of family members on
those of the affected probands plus one extra affected
individual per kindred. No transformation was per-
formed for either trait, since the coefficients of skewness
for variable K and apoB were 0.23 and 0.68, respec-
tively. Figure 1 shows a histogram and a QQ plot, which
do not seriously violate normality, for each trait. Fur-
thermore, we included the environmental model in the
segregation analysis, which reduced the possibility that
skewedness alone leads to false detection of a major gene
(Demenais et al. 1986).
Model Hypothesis and Comparison
We first tested the total genetic correlation between
these two traits. In table 1, we fit the data to model 1,
which was a polygenic model without the genetic cor-
relation, and to model 2, which was another polygenic
model with the genetic correlation. Comparison between
these two models indicated the significance of the total
genetic correlation. Then we further explored the source
of the genetic correlation by modeling a major gene ef-
fect—that is, we assumed that the significant genetic cor-
relation was caused by a common major gene. For one-
gene Mendelian models, the modes of transmission can
be dominant, recessive, or codominant for each trait.
Thus there are nine possible combinations in one-gene
bivariate models. A one-factor environmental model
(model 6) was considered an alternative model in which
three transmission parameters were equal to the fre-
quency of a major environmental factor, PL. A one-gene
general bivariate model (model 7) in which three trans-
mission parameters were free to be estimated was fit as
the reference model. We also tested a two-gene Men-
delian model (model 8) in which each trait has its cor-
responding single major gene. We compared the fit of
this two-gene model with those from the one-gene gen-
eral model and the best-fitting one-gene bivariate Men-
delian model, to further test the hypothesis of a common
major gene.
Two criteria were employed to compare these models.
For hierarchical models, the likelihood ratio test (LRT)
was used. Twice the difference in log likelihoods
( ) between a restricted model and an unrestricted2 lnL
model is asymptotically distributed as a x2 statistic, with
degrees of freedom equal to the difference in the number
of parameters fit under the two models. The most par-
simonious model is the one requiring the fewest esti-
mated parameters while giving a log likelihood not sig-
nificantly smaller than the most general model. When
comparing nonhierarchical models, however, the
Akaike’s Information Criterion (AIC) was used (Akaike
1974). The AIC is equal to , where n is the2 lnL 2n
number of parameters estimated in the models. By this
criterion, the most parsimonious model is the one with
the smallest AIC score.
Results
Sample
There were 40 multigenerational families (two to four
generations) in which 623 individuals had data on ad-
justed variable K and 607 individuals had adjusted apoB
values. Our previous study (Bredie et al. 1997) showed
possible etiologic heterogeneity for apoB inheritance in
this population. One family containing 12 individuals
(in two of whom apoB data were missing) was found
to strongly indicate an environmental transmission
model, and thus this family was excluded for segregation
analysis of apoB. In the bivariate analysis, apoB values
in this family were coded as missing. Therefore, apoB
Table 1
Bivariate Segregation Analysis of Variable K and apoB Levels
MODELa PL PA
VARIABLE K APOB LEVELS
rG rE 2lnL AIC LRT (P Value)
bmLL mHL mHH jK
2hK mAA mAB mBB japoB
2hapoB
1. Sporadic I [1] )c .32 mLL mLL 1.29 .33 126.45 mAA mAA 28.66 .23 [0] .51 9199.4 9213.4 (!.001)2x  72.89
2. Sporadic II [1] )c .13 mLL mLL 1.31 .44 123.43 mAA mAA 29.03 .34 .81 .27 9167.8 9183.8 (!.001)2x  41.28
3. Rec-Cod .98 )c .03 mLL 1.90 1.22 .41 123.80 123.47 234.76 28.62 .37 .81 .33 9140.3 9164.3 (.01)2x  13.74
4. Cod-Cod I .60 )c .59 .06 1.84 .94 .13 113.64 120.82 155.39 23.65 .09 .26d .17 9132.3 9158.3 (.13)2x  5.73
5. Cod-Cod II .60 )c .58 .05 1.83 .94 .14 113.97 120.60 155.24 23.73 .11 [0] .15 9132.5 9156.5 (.21)2x  5.94
6. Environmentale .89 )c .26 1.02 .74 1.23 .45 125.07 112.63 203.85 27.18 .42 .72 .15 9153.8 9179.8 (.001)2x  27.23
7. One-gene generalf .71 )c .58 .33 1.96 .94 .12 110.38 125.51 160.13 21.88 .05 .81d .11 9126.6 9158.6 )
8. Two-gene .74 .42 .12 .11 2.03 1.18 .43 116.90 114.87 201.14 26.04 .25 .99g .39 9150.5 9178.5 )
NOTE.—Brackets indicate that the value was fixed.
a Rec  recessive; and cod  codominant.
b LRT  likelihood-ratio test. P values were from comparisons between each restricted model (models 1–6) and the one-gene general model (model 7).
c We assumed the second gene for apoB levels is the same as the first gene for K values.
d Both parameters are not significant because of large standard errors ( and )..26 .84 .81 1.61
e The three transmission parameters are equal to PL.
f The three transmission parameters are .90, .39, and .08.
g The parameter was fixed by the maximum-likelihood algorithm.
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analysis was based on 597 individuals. 571 individuals
had data on both traits.
Adjustment for Covariates and the Spearman
Correlation
Environmental factors included in the multiple linear
regression analysis accounted for 24% of the variance
of variable K (Bredie et al. 1996). For apoB, the envi-
ronmental factors explained 36% of the variance of
apoB (Bredie et al. 1997). The crude Spearman corre-
lation coefficient between two traits was0.65, and the
coefficient decreased to 0.47 after adjustment for en-
vironmental factors.
Segregation Analysis
The total genetic component for each trait was esti-
mated to be 0.44 for adjusted K and 0.34 for adjusted
apoB on the basis of model 2 (table 1) (these estimates
are identical to those obtained from univariate models,
data for which are not shown). Model 2 fit much better
than model 1 ( ). This suggested significantp ! 0.0001
genetic correlation between these two traits. We further
calculated the total genetic and environmental correla-
tions between these two traits on the basis of parameters
in model 2 using the formula mentioned in the Material
and Methods section (Lynch and Walsh 1998). The total
genetic correlation was 0.31, the environmental cor-
relation was 0.16, and the sum of them was equal to
a total phenotypic correlation (i.e., the Spearman cor-
relation) of 0.47. It should be noted that a predomi-
nance of small, dense LDL particles is associated with
high apoB levels. The negative value for the correlation
indicates this inverse association.
As mentioned above, we tested nine different one-gene
bivariate Mendelian models. In table 1, we present only
informative models. Our previous report of variable K
(Bredie et al. 1996) showed that neither the codominant
nor the recessive model could be rejected, although the
recessive model was more parsimonious than the co-
dominant model. Analysis of apoB (Bredie et al. 1997)
showed that the codominant model fit these data best.
Therefore, we were particularly interested in two types
of bivariate models: one recessive for variable K and
codominant for apoB (model 3) and the other codom-
inant for both traits (models 4 and 5). After comparison
of the one-gene models 1–6 with the one-gene general
model 7, all were rejected except models 4 and 5. Note
that the estimated genetic correlation in model 4 reversed
to a positive value of 0.26 but with a large standard
error of 0.84. This suggested that the residual genetic
correlation beyond the common major gene is negligible.
Therefore, we further tested a similar model with the
residual genetic correlation fixed at zero (model 5). In
comparison of the likelihoods between models 4 and 5,
model 5 fit as well as model 4, and the parameters in
both models were similar. Model 5 was considered more
parsimonious than model 4. Model 8 includes two in-
dependent genes, and each gene has its single corre-
spondent trait. Thus, it is conceptually different from
one-gene models. The AIC scores were used to compare
model 8 with model 5 and with the one-gene general
model 7. Model 8 had a worse fit as judged by the AIC
scores. Thus model 5 had the best fit among all the
competing models. We concluded that a common major
gene accounted for most genetic components shared be-
tween both traits.
For Mendelian models of inheritance, the variance due
to a major gene (Boerwinkle and Sing 1986) is computed
as
l I 12 2 2( )j  f m  m  j ,ML i i Tnil
where m is the overall mean, mi is the estimated mean of
the ith genotype (i 1, 2, 3, .., I), fi is its genotypic
frequency, n is the total number of individuals, and j2T
is the total variance of phenotypic values. The ratio
provides the major gene contribution to the phe-2 2j /jML T
notypic variance. In the best-fitting model 5, the major
gene explained 37% of the variance in the adjusted K
values and 23% of that in adjusted apoB levels. The
residual genetic correlation of zero in model 5 indicated
distinct residual polygenes for each trait. The residual
polygenes for variable K explained 7% of the variance
in variable K values (as calculated by , param-2 2 2h j /jK K T
eters from model 5), and the residual polygenes for apoB
also explained 7% of the variance of apoB levels. The
total environmental correlation in model 5 is equal to
0.13, which was close to the original estimate in model
2.
Discussion
Evidence of a common genetic mechanism controlling
both apoB levels and distribution of LDL subfraction
profiles (represented by variable K) in FCH families is
supported from the present bivariate segregation anal-
ysis. The best-fitting model has a common major gene
with codominant alleles for both traits, plus distinct
polygenes for each trait. The significant decrease in the
residual genetic correlation in model 5 supports the hy-
pothesis that a common major gene regulates these two
traits.
In the univariate analysis of variable K, the recessive
model was considered more parsimonious than the co-
dominant model, although neither could be rejected
when compared to the most general model (Bredie et al.
1996). However, both the recessive and codominant
models provided similar information—predicting a
592 Am. J. Hum. Genet. 63:586–594, 1998
dense LDL subfraction profile in ∼17% of the popula-
tion and either an intermediate or a buoyant subfraction
profile in the other 83% of the population. Thus, co-
dominant inheritance of variable K in this present bi-
variate analysis was not in disagreement with our pre-
vious study (Bredie et al. 1996). Further comparison
between the estimated parameters in our best-fitting bi-
variate model and those in the best-fitting univariate
models of variable K and apoB (Bredie et al. 1996, 1997)
showed they are similar in terms of allele frequency and
genotypic means.
On the basis of a larger major gene effect on variable
K than apoB and the consistent mode of transmission
between both traits, we hypothesized that the major gene
has a primary effect on LDL heterogeneity with a car-
ryover effect on apoB levels. This hypothesis is in concert
with the observation that the distribution of LDL par-
ticle sizes was less affected by environment than were
the apoB levels (Hokanson et al. 1993). Hokanson et
al. (1995) also reported that the primary increase in
plasma apoB levels in the FCH patients was accounted
for by significant increases in apoB in denser LDL par-
ticles. This may also suggest that increasing the number
of denser LDL particles results in elevated apoB levels.
Analysis of the chemical properties of lipoproteins
showed that not only LDL particles but also VLDL and
IDL from FCH patients had higher lipoprotein mass
than controls (Hokanson et al. 1995). Since only one
apoB molecule is present on each LDL and VLDL par-
ticle, it is reasonable to hypothesize that a defective gene
(or genes) that increases assembly or formation of small,
dense lipoproteins leads to an increased number of par-
ticles and thus results in elevated apoB levels. If this
biological model is accurate, the bivariate model pre-
sented here truly reflects the relation between LDL par-
ticles and apoB levels.
However, both Jarvik et al. (1994) and Austin et al.
(1992) reported distinct genetic mechanisms for LDL
subclass phenotype (a dichotomized phenotype of LDL
particle size) and apoB levels in FCH families. These
conflicting results could have several possible causes. Jar-
vik et al. (1994) first conducted a segregation analysis
of apoB concentration and then calculated the proba-
bility of each individual’s genotype under the best-fitting
model of apoB concentrations. They found no associa-
tion between these predicted apoB level genotypes and
LDL subclass phenotypes. However, the assignment of
individual’s genotype was made on the basis of an ar-
bitrary cutoff point of genotype probability, which could
lead to unknown degrees of misclassification. This prob-
lem can be more serious if more than one underlying
major gene determines apoB levels. A similar method
has been applied to our data set, leading to a conclusion
of separate genetic mechanisms for variable K and apoB
levels (data not shown). Although Jarvik et al. (1994)
justified their conclusions by showing a major gene in
segregation analysis of LDL subclass–adjusted apoB, the
adjustment by regression models that used average in-
formation could leave significant residual effects. We
have repeated a similar strategy in our data and also
found a major effect on apoB-adjusted variable K (data
not shown). In other words, we used these indirect meth-
ods in our data set and found that the results were the
opposite of those from the direct bivariate analysis. Aus-
tin et al. (1992) used commingling analysis of apoB in
FCH families and reported that the gene regulating LDL
subclass phenotype could not explain apoB levels. Their
conclusions were made on the basis of a bimodal dis-
tribution of apoB levels in a subset of 54 individuals
who had LDL subclass B (i.e., small, dense LDL parti-
cles). In the Austin et al. (1992) analysis, individuals with
LDL subclass B were selected from 78 nuclear families;
therefore, the family structure was broken and infor-
mation from other relatives could not be incorporated
into the subset analysis. Furthermore, because of the
small sample size, their results were more subject to sam-
ple variation. Jarvik et al. (1994) found a major gene
effect on apoB levels in individuals with LDL subclass
A; Austin et al. (1992) did not find similar results in
such individuals. The etiology of elevated apoB levels
can be heterogeneous (Coresh et al. 1993; Bredie et al.
1997). The conflicting results of the present study and
the two previous studies (Austin et al. 1992; Jarvik et
al. 1994) may reflect the complexity of the genetic mech-
anisms for these traits.
There are some limitations in our study. We did not
test gene-environment interaction in the segregation
models. Our sample was a highly selected population,
which makes adequate ascertainment correction un-
likely. Therefore, the interpretation of our results needs
to be conservative.
Our study, which used a more direct statistical ap-
proach and a larger sample size, supported the hypo-
thesis of a common genetic mechanism for apoB levels
and LDL subfraction profiles. Furthermore, our results
are more consistent with results from metabolic studies.
For future genetic studies of FCH, especially linkage
analyses, use of a subset of families in which individuals
have a predominance of small, dense LDL particles as
well as high apoB levels may be able to minimize etio-
logic heterogeneity.
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